Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

NCT01773278 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Smith-Lemli-Opitz Syndrome
Cone-Rod Dystrophy
Hearing Loss

Interventions

DRUG: Antioxidants
DRUG: Cholesterol

Sponsor

University of Colorado, Denver